169 related articles for article (PubMed ID: 33390656)
1. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of prostaglandin EP4 receptor in three canine carcinomas.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
BMC Vet Res; 2020 Jun; 16(1):213. PubMed ID: 32571310
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin EP4 receptor mRNA expression in canine lymphoma.
Musser ML; Viall AK; Phillips RL; Fasina O; Johannes CM
Vet Comp Oncol; 2022 Mar; 20(1):127-133. PubMed ID: 34250711
[TBL] [Abstract][Full Text] [Related]
4. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
5. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone gene expression in canine normal growth plates and spontaneous osteosarcoma.
Kirpensteijn J; Timmermans-Sprang EP; van Garderen E; Rutteman GR; Lantinga-van Leeuwen IS; Mol JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):179-85. PubMed ID: 12431811
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
Sottnik JL; Thamm DH
Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
10. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
12. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
13. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
15. Characterization of β-catenin expression in canine osteosarcoma.
Stein TJ; Holmes KE; Muthuswamy A; Thompson V; Huelsmeyer MK
Vet Comp Oncol; 2011 Mar; 9(1):65-73. PubMed ID: 21303455
[TBL] [Abstract][Full Text] [Related]
16. The animal-dependent risk factors in canine osteosarcomas.
Sapierzyński R; Czopowicz M
Pol J Vet Sci; 2017 Mar; 20(2):293-298. PubMed ID: 28865206
[TBL] [Abstract][Full Text] [Related]
17. Expression of connexins in normal and neoplastic canine bone tissue.
Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
[TBL] [Abstract][Full Text] [Related]
18. Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
de Sá Rodrigues LC; Holmes KE; Thompson V; Newton MA; Stein TJ
Vet Comp Oncol; 2017 Mar; 15(1):78-93. PubMed ID: 25689105
[TBL] [Abstract][Full Text] [Related]
19. Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.
Gebhard C; Fuchs-Baumgartinger A; Razzazi-Fazeli E; Miller I; Walter I
Can J Vet Res; 2016 Jan; 80(1):66-73. PubMed ID: 26733734
[TBL] [Abstract][Full Text] [Related]
20. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
